357 related articles for article (PubMed ID: 19515851)
41. Prion-like properties of pathological TDP-43 aggregates from diseased brains.
Nonaka T; Masuda-Suzukake M; Arai T; Hasegawa Y; Akatsu H; Obi T; Yoshida M; Murayama S; Mann DM; Akiyama H; Hasegawa M
Cell Rep; 2013 Jul; 4(1):124-34. PubMed ID: 23831027
[TBL] [Abstract][Full Text] [Related]
42. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
43. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.
Saini A; Chauhan VS
Chembiochem; 2011 Nov; 12(16):2495-501. PubMed ID: 21905193
[TBL] [Abstract][Full Text] [Related]
44. Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments.
Zhang YJ; Gendron TF; Xu YF; Ko LW; Yen SH; Petrucelli L
Mol Neurodegener; 2010 Aug; 5():33. PubMed ID: 20804554
[TBL] [Abstract][Full Text] [Related]
45. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
46. p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions.
Tanji K; Zhang HX; Mori F; Kakita A; Takahashi H; Wakabayashi K
J Neurosci Res; 2012 Oct; 90(10):2034-42. PubMed ID: 22674379
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43.
Nonaka T; Suzuki G; Tanaka Y; Kametani F; Hirai S; Okado H; Miyashita T; Saitoe M; Akiyama H; Masai H; Hasegawa M
J Biol Chem; 2016 Mar; 291(11):5473-5483. PubMed ID: 26769969
[TBL] [Abstract][Full Text] [Related]
48. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.
Wang X; Fan H; Ying Z; Li B; Wang H; Wang G
Neurosci Lett; 2010 Jan; 469(1):112-6. PubMed ID: 19944744
[TBL] [Abstract][Full Text] [Related]
49. TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.
Qin H; Lim LZ; Wei Y; Song J
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18619-24. PubMed ID: 25503365
[TBL] [Abstract][Full Text] [Related]
50. Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis.
Chen AK; Lin RY; Hsieh EZ; Tu PH; Chen RP; Liao TY; Chen W; Wang CH; Huang JJ
J Am Chem Soc; 2010 Feb; 132(4):1186-7. PubMed ID: 20055380
[TBL] [Abstract][Full Text] [Related]
51. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1.
Brady OA; Meng P; Zheng Y; Mao Y; Hu F
J Neurochem; 2011 Jan; 116(2):248-59. PubMed ID: 21062285
[TBL] [Abstract][Full Text] [Related]
52. Zinc induces depletion and aggregation of endogenous TDP-43.
Caragounis A; Price KA; Soon CP; Filiz G; Masters CL; Li QX; Crouch PJ; White AR
Free Radic Biol Med; 2010 May; 48(9):1152-61. PubMed ID: 20138212
[TBL] [Abstract][Full Text] [Related]
53. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils.
Shimonaka S; Nonaka T; Suzuki G; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Apr; 291(17):8896-907. PubMed ID: 26887947
[TBL] [Abstract][Full Text] [Related]
54. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.
Zhang YJ; Xu YF; Dickey CA; Buratti E; Baralle F; Bailey R; Pickering-Brown S; Dickson D; Petrucelli L
J Neurosci; 2007 Sep; 27(39):10530-4. PubMed ID: 17898224
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.
Coudert L; Nonaka T; Bernard E; Hasegawa M; Schaeffer L; Leblanc P
Cell Mol Life Sci; 2019 Jul; 76(13):2615-2632. PubMed ID: 30863908
[TBL] [Abstract][Full Text] [Related]
56. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.
Romano V; Quadri Z; Baralle FE; Buratti E
Prion; 2015; 9(1):1-9. PubMed ID: 25635624
[TBL] [Abstract][Full Text] [Related]
57. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains.
Seyfried NT; Gozal YM; Dammer EB; Xia Q; Duong DM; Cheng D; Lah JJ; Levey AI; Peng J
Mol Cell Proteomics; 2010 Apr; 9(4):705-18. PubMed ID: 20047951
[TBL] [Abstract][Full Text] [Related]
58. Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.
Li HY; Yeh PA; Chiu HC; Tang CY; Tu BP
PLoS One; 2011; 6(8):e23075. PubMed ID: 21850253
[TBL] [Abstract][Full Text] [Related]
59. Activation of transforming growth factor-β/Smad signaling reduces aggregate formation of mislocalized TAR DNA-binding protein-43.
Nakamura M; Kaneko S; Ito H; Jiang S; Fujita K; Wate R; Nakano S; Fujisawa J; Kusaka H
Neurodegener Dis; 2013; 11(4):182-93. PubMed ID: 22797246
[TBL] [Abstract][Full Text] [Related]
60. Fluorescence in-situ hybridization method reveals that carboxyl-terminal fragments of transactive response DNA-binding protein-43 truncated at the amino acid residue 218 reduce poly(A)+ RNA expression.
Higashi S; Watanabe R; Arai T
Neuroreport; 2018 Jul; 29(10):846-851. PubMed ID: 29742622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
